Journey Medical plans to highlight the launch of Emrosiâ„¢ and showcase its line of prescription dermatology products. The FDA approved Emrosi for the treatment of inflammatory lesions of rosacea in ...
Johnson & Johnson (NYSE:JNJ) 45th Annual TD Cowen Healthcare Conference March 4, 2025 11:10 AM ETCompany ParticipantsTim Schmid - Executive ...
Johnson & Johnson MedTech‘s Shockwave Medical announced the U.S. launch of its Javelin peripheral intravascular lithotripsy ...
We recently compiled a list of the 15 Best S&P 500 Dividend Stocks to Buy Now. In this article, we are going to take a look ...